Return On Assets of AVADEL PHARMACEUTICALS PLC from 31 Mar 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
AVADEL PHARMACEUTICALS PLC quarterly and annual Return On Assets in % history and change rate from 31 Mar 2014 to 30 Sep 2025.
  • AVADEL PHARMACEUTICALS PLC Return On Assets for the quarter ending 30 Sep 2025 was 11%.
  • AVADEL PHARMACEUTICALS PLC annual Return On Assets for 2024 was -30%, a 67% increase from 2023.
  • AVADEL PHARMACEUTICALS PLC annual Return On Assets for 2023 was -90%, a 8.1% decline from 2022.
  • AVADEL PHARMACEUTICALS PLC annual Return On Assets for 2022 was -84%, a 194% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 11% +56% 01 Jul 2025 30 Sep 2025
Q2 2025 -2% +60% +97% 01 Apr 2025 30 Jun 2025
Q1 2025 -16% +69% +81% 01 Jan 2025 31 Mar 2025
Q4 2024 -30% +60% +67% 01 Oct 2024 31 Dec 2024
Q3 2024 -45% +49% +52% 01 Jul 2024 30 Sep 2024
Q2 2024 -61% +31% +33% 01 Apr 2024 30 Jun 2024
Q1 2024 -85% +13% +13% 01 Jan 2024 31 Mar 2024
Q4 2023 -90% -7% -8.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -94% -25% -37% 01 Jul 2023 30 Sep 2023
Q2 2023 -92% -32% -53% 01 Apr 2023 30 Jun 2023
Q1 2023 -98% -63% -176% 01 Jan 2023 31 Mar 2023
Q4 2022 -84% -55% -194% 01 Oct 2022 31 Dec 2022
Q3 2022 -69% -46% -198% 01 Jul 2022 30 Sep 2022
Q2 2022 -60% -42% -227% 01 Apr 2022 30 Jun 2022
Q1 2022 -36% -34% -1941% 01 Jan 2022 31 Mar 2022
Q4 2021 -28% -31% -1303% 01 Oct 2021 31 Dec 2021
Q3 2021 -23% -29% -480% 01 Jul 2021 30 Sep 2021
Q2 2021 -18% -27% -315% 01 Apr 2021 30 Jun 2021
Q1 2021 -2% +11% +86% 01 Jan 2021 31 Mar 2021
Q4 2020 2% +23% 01 Oct 2020 31 Dec 2020
Q3 2020 6% +61% 01 Jul 2020 30 Sep 2020
Q2 2020 9% +59% 01 Apr 2020 30 Jun 2020
Q1 2020 -12% +29% +70% 01 Jan 2020 31 Mar 2020
Q4 2019 -21% +14% +40% 01 Oct 2019 31 Dec 2019
Q3 2019 -55% -41% -305% 01 Jul 2019 30 Sep 2019
Q2 2019 -51% -50% -6566% 01 Apr 2019 30 Jun 2019
Q1 2019 -41% -52% -492% 01 Jan 2019 31 Mar 2019
Q4 2018 -34% -61% -232% 01 Oct 2018 31 Dec 2018
Q3 2018 -14% -45% -143% 01 Jul 2018 30 Sep 2018
Q2 2018 -1% -16% -105% 01 Apr 2018 30 Jun 2018
Q1 2018 11% +14% 01 Jan 2018 31 Mar 2018
Q4 2017 26% +43% 01 Oct 2017 31 Dec 2017
Q3 2017 31% +19% +160% 01 Jul 2017 30 Sep 2017
Q2 2017 16% 01 Apr 2017 30 Jun 2017
Q1 2017 -4% 01 Jan 2017 31 Mar 2017
Q4 2016 -17% 01 Oct 2016 31 Dec 2016
Q3 2016 12% 01 Jul 2016 30 Sep 2016
Q2 2015 -24% +9% +27% 01 Apr 2015 30 Jun 2015
Q1 2015 -27% +19% +41% 01 Jan 2015 31 Mar 2015
Q4 2014 -49% 01 Oct 2014 31 Dec 2014
Q3 2014 -33% 01 Jul 2014 30 Sep 2014
Q2 2014 -33% 01 Apr 2014 30 Jun 2014
Q1 2014 -46% 01 Jan 2014 31 Mar 2014

AVADEL PHARMACEUTICALS PLC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -30% +60% +67% 01 Jan 2024 31 Dec 2024
2023 -90% -7% -8.1% 01 Jan 2023 31 Dec 2023
2022 -84% -55% -194% 01 Jan 2022 31 Dec 2022
2021 -28% -31% -1303% 01 Jan 2021 31 Dec 2021
2020 2% +23% 01 Jan 2020 31 Dec 2020
2019 -21% +14% +40% 01 Jan 2019 31 Dec 2019
2018 -34% -61% -232% 01 Jan 2018 31 Dec 2018
2017 26% +43% 01 Jan 2017 31 Dec 2017
2016 -17% 01 Jan 2016 31 Dec 2016
2014 -49% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.